Compare Sumi Indo Kabel Tbk. (IKBI) vs Indofarma Tbk. (INAF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumi Indo Kabel Tbk. vs Indofarma Tbk. — how do they compare? Sumi Indo Kabel Tbk. trades at Rp555 (market cap 691.56B, 1.4M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Sumi Indo Kabel Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| IKBI | INAF | |
|---|---|---|
Market Cap | 691.56B | 390.51B |
Volume | 1.4M | — |
Lot | 14.02K | — |
Turnover | 779.16M | — |
Average Price | 555.91 | — |
Value | 779.16M | — |
Indicative Equilibrium Price | 555 | — |
Indicative Equilibrium Volume | 49 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumi Indo Kabel Tbk.
The Company was established on July 23, 1981 with its Head Office and Factory located in Tangerang, West Java. The Company was listed in JSX and SSX in 1990. On 1994 the Company changed status of the Company to become Foreign Capital Investment (PMA), right after participation of Sumitomo Electric Industries, Ltd., Japan which is one of the biggest in the world in cable industry and PT Perdanamulia Ekasakti.
Read more on IKBI →About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →
